Medicinal Chemistry Journal of Medicinal Chemistry

A fumarate handle turns a TTK inhibitor into a monovalent degrader

  • Appending a monomethyl fumarate electrophile to a TTK inhibitor gives a single-warhead degrader, with no bifunctional PROTAC linker needed.
  • The lead compound depletes TTK and outperforms the parent inhibitor in antiproliferative assays across several cancer lines.
  • Mechanistic work points to the E3 ligase RNF126, which the compound recruits and holds in contact with TTK, driving ubiquitination and proteasomal turnover.
  • Authors present it as a molecular glue-like TTK degrader and the fumarate as a handle with less nonspecific cytotoxicity.
Points Based on the abstract

The central question is whether this is a true glue-like ternary complex or just a covalent adduct on an RNF126 cysteine. A saturated succinate analogue would show whether the Michael acceptor is essential, and proteome-wide reactivity profiling would be needed to back the selectivity claim. Tractability looks better than a PROTAC, though the exit vector from the kinase pocket probably dictates the SAR.